Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Month of Birth Does Not Seem to Interfere with the Development of Multiple Sclerosis Later in Life in Brazilian Patients.
Optic neuritis in a child with biotinidase deficiency: case report and literature review.
Group exercise training for balance, functional status, spasticity, fatigue and quality of life in multiple sclerosis: a randomized controlled trial.
Transcriptional enhancers: from properties to genome-wide predictions.
PLEGRIDY™ (peginterferon beta-1a) two-year data confirm maintenance of efficacy and safety in multiple sclerosis patients
Incidence of Mood or Anxiety Disorders in Children of Parents with Multiple Sclerosis.
Symptom overlap in anxiety and multiple sclerosis.
Individual variability in speed of information processing: An index of cognitive impairment in multiple sclerosis.
Autoimmunity: Rubbing salt in the wound.
Proton Density MRI Increases Detection of Cervical Spinal Cord Multiple Sclerosis Lesions Compared with T2-Weighted Fast Spin-Echo.
Gray matter is targeted in first-attack multiple sclerosis.
Outcome and survival of asymptomatic PML in natalizumab-treated MS patients.
What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in sweden.
Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Multiple sclerosis disease-modifying therapy prescribing patterns in ontario.
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort.
Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
The effect of supported standing in adults with upper motor neurone disorders: a systematic review.
Tractography Analysis of 5 White Matter Bundles and Their Clinical and Cognitive Correlates in Early-Course Schizophrenia.
New data at AAN to confirm efficacy of Novartis' Gilenya® across four key measures of MS disease activity, including brain volume loss
Study shows promising efficacy for peginterferon beta-1a in multiple sclerosis
Platelets provide a bounty of potential targets for therapy in multiple sclerosis.
Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis.

Pages